RNU6-977P

Across TCGA pan-cancer cohorts, RNU6-977P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-977P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU6-977P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-977P expression acts as an unfavorable survival marker, although some lineages such as UCS and COAD show a favorable association.

READ, LUAD, and DLBC are the cancer types where RNU6-977P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	III,IV	0.111	0.890	<.001	63	view →
LUAD	DFS	Tertile	IV	0.045	0.717	<.001	54	view →
DLBC	DFS	Tertile	II,III,IV	0.022	0.837	<.001	36	view →
UCEC	DFS	Tertile	All	0.247	0.676	.011	36	view →
THCA	OS	Tertile	II,III,IV	0.173	0.903	<.001	36	view →
LIHC	DFS	Tertile	III,IV	0.086	0.364	.003	36	view →
OV	OS	Tertile	All	0.620	0.714	.004	30	view →
KIRC	DFS	Tertile	IV	0.287	0.631	.002	18	view →
UCS	DFS	Tertile	IV	0.996	0.570	.039	18	view →
MESO	OS	Tertile	II,III,IV	0.266	0.572	.008	18	view →
ESCA	OS	Median	All	0.682	1.000	.029	12	view →
COAD	OS	Tertile	All	1.000	0.586	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-977P–READ (OS)

Open the READ breakdown →